Using indocyanine green imaging to treat cystic lymphatic malformation in children

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of indocyanine green-fluorescence imaging in the management of cystic lymphatic malformation (cLM) in children. Participants will undergo imaging before surgery, while a control group will receive traditional surgical methods. The study will compare the outcomes of both approaches to determine the potential benefits of using this imaging technique in diagnosis and treatment. The findings could enhance understanding of cLM and improve surgical interventions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

(1) no previous intervention; (2) cLM diagnosed by pretreatment magnetic resonance imaging (MRI); (3)3 to 6 months post-treatment follow-up; (4) Superfacial cLM

Exclusion Criteria:

(1) history of iodine allergy; (2) syndromic cLM ; (3) severe liver and kidney dysfunction; (4) intralesional hemorrhage; (5) intralesional infection

Where it's running

• Children's hospital of Nanjing medical university
  Nanjing, Jiangsu, China Recruiting

Study contacts

• Study coordinator: Tao Han, Dr.
• Email: dr.hantao@njmu.edu.cn
• Phone: +86 186 5190 3495

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Registry and biobank for lymphatic malformations in Italy

  This study is creating a registry and biobank to collect information and samples from people with lymphatic malformations in Italy to improve understanding and treatment of these rare conditions.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma · NCT06892964

• Using sirolimus to treat cystic lymphatic malformations in children

  This study is testing different doses of sirolimus to see if it can safely help children with cystic lymphatic malformations.

  Recruiting Phase 2/3 West China Hospital · Chengdu, Sichuan · NCT06673290

• Using Bleomycin for treating lymphatic malformations in children

  This study is testing whether different strengths of Bleomycin can safely treat lymphatic malformations in children under 14 that can't be removed with surgery.

  Recruiting Phase 2 West China Hospital · Chengdu, Sichuan · NCT06437158

• Targeted therapies for patients with vascular malformations

  This study is testing new targeted treatments for patients with slow-flow and fast-flow vascular malformations to see if they work better than the usual therapies.

  Recruiting at 2 sites Phase 2 Murdoch Childrens Research Institute · Parkville, Victoria and 1 other locations · NCT05983159

• Treatment of lymphatic malformations in children using TARA-002

  This study is testing if a new treatment called TARA-002 can safely help reduce lymphatic malformations in children aged 6 months to under 18 years.

  Recruiting at 9 sites Phase 2 Protara Therapeutics · Birmingham, Alabama and 10 other locations · NCT05871970

• Weekly treatment with sirolimus for venous and lymphatic malformations

  This study is testing if giving sirolimus once a week can help people with venous and lymphatic malformations feel better while causing fewer side effects than taking it every day.

  Recruiting Phase 2 Medical University of South Carolina · Charleston, South Carolina · NCT04861064

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.